Products

Alerts

Watchlists

Home

Alerts

Watchlists

Products

Parenteral Drugs (India) Ltd

PDPL

NSE

₹ 2.90

Alert

Watchlist

Note

Industry:

Pharmaceuticals - I V Fluids

Parenteral Drugs (India) Ltd

PDPL

NSE

₹ 2.90

Add Alert

Add to Watchlist

Edit Note

Industry

Pharmaceuticals - I V Fluids

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Financials

Corporate Actions

Segments

Shareholdings

Documents

Calculators

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Price

Charts

Documents

Quick Ratios

Edit Ratios

Mkt Cap

Market Capitalization

₹9Cr

Close Price

₹2.90

Industry

Pharmaceuticals - I V Fluids

Price To Earnings

Price To Sales

1.02

Revenue

₹9Cr

Rev Gr TTM

Revenue Growth TTM

-30.16%

PAT Gr TTM

PAT Growth TTM

-37.26%

Quarterly Results

Consolidated

Standalone

Numbers

Percentage

Quarter	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022
Revenue RevenueCr	9	7	7	9	3	5	2	3	3	2	1	2
Growth YoY Revenue Growth YoY%	-82.2	-17.4	-28.9	259.0	-66.5	-36.8	-71.8	-70.0	0.3	-49.4	-29.4	-31.1
Expenses ExpensesCr	13	11	10	13	9	11	5	-1	6	6	5	8
Operating Profit Operating ProfitCr	-4	-4	-3	-4	-6	-6	-3	3	-3	-3	-3	-6
OPM OPM%	-45.5	-50.0	-40.9	-47.5	-199.3	-139.2	-140.2	131.9	-90.1	-139.2	-224.3	-332.8
Other Income Other IncomeCr	0	0	0	0	0	0	0	0	0	0	0	52
Interest Expense Interest ExpenseCr	26	27	28	29	30	31	32	32	34	35	37	0
Depreciation DepreciationCr	4	4	4	4	4	4	4	4	4	4	4	27
PBT PBTCr	-34	-35	-35	-37	-40	-42	-39	-33	-41	-43	-44	19
Tax TaxCr	-7	-7	-9	-5	-8	-8	-8	-9	-9	-9	-10	-5
PAT PATCr	-28	-28	-26	-32	-32	-34	-31	-25	-32	-34	-35	24
Growth YoY PAT Growth YoY%	-12.7	-5.4	-3.5	55.6	-16.4	-18.9	-18.5	22.2	0.6	0.2	-11.5	195.8
NPM NPM%	-317.6	-385.7	-361.1	-372.1	-1,103.4	-725.6	-1,518.1	-966.9	-1,093.5	-1,430.2	-2,397.2	1,345.2
EPS EPS	-9.3	-9.5	-8.8	-10.7	-10.8	-11.3	-10.4	-8.3	-10.7	-11.3	-11.6	8.0

Profit & Loss

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Revenue RevenueCr	333	327	274	263	260	230	224	32	32	12	9
Growth Revenue Growth%		-1.5	-16.4	-4.0	-0.9	-11.7	-2.5	-85.7	-0.4	-61.8	-30.1
Expenses ExpensesCr	319	341	350	248	296	249	225	50	47	24	24
Operating Profit Operating ProfitCr	14	-14	-76	14	-36	-19	-1	-18	-15	-12	-15
OPM OPM%	4.2	-4.3	-27.7	5.5	-13.7	-8.4	-0.5	-55.2	-46.1	-96.8	-176.6
Other Income Other IncomeCr	0	0	61	1	2	3	2	1	0	0	52
Interest Expense Interest ExpenseCr	48	56	60	70	70	86	98	96	110	125	106
Depreciation DepreciationCr	14	23	19	31	23	25	24	69	17	17	40
PBT PBTCr	-49	-93	-47	-86	-127	-127	-121	-181	-142	-154	-109
Tax TaxCr	5	15	-1	-19	-10	-10	-10	-33	-28	-33	-33
PAT PATCr	-53	-108	-45	-68	-117	-118	-112	-148	-114	-122	-76
Growth PAT Growth%		-102.1	58.1	-49.8	-72.3	-1.1	5.1	-32.3	22.9	-6.7	37.3
NPM NPM%	-16.1	-32.9	-16.5	-25.8	-44.8	-51.3	-49.9	-462.0	-357.9	-1,000.3	-898.4
EPS EPS	-20.6	-41.7	-15.2	-22.7	-39.1	-39.5	-39.9	-49.6	-38.3	-40.8	-25.6

Balance Sheet

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Equity Capital Equity CapitalCr	26	26	30	30	30	30	30	30	30	30	30
Reserves ReservesCr	272	192	157	82	278	-90	-209	-511	-626	-747	-854
Current Liabilities Current LiabilitiesCr	254	162	166	230	300	428	593	878	1,006	1,144	1,201
Non Current Liabilities Non Current LiabilitiesCr	246	427	456	427	440	503	434	110	107	107	107
Total Liabilities Total LiabilitiesCr	850	835	825	785	1,066	914	890	541	552	568	484
Current Assets Current AssetsCr	201	192	200	235	163	122	99	67	67	68	67
Non Current Assets Non Current AssetsCr	648	643	625	550	903	792	791	473	484	500	417
Total Assets Total AssetsCr	850	835	825	785	1,066	914	890	541	552	568	484

Cash Flow

Consolidated

Standalone

Financial Year	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Operating Cash Flow Operating Cash FlowCr	20	-168	-60	2	58	134	167	477	112	125	0
Investing Cash Flow Investing Cash FlowCr	-147	-18	33	3	-110	-1	-1	97	0	0	65
Financing Cash Flow Financing Cash FlowCr	133	182	25	-10	54	-134	-167	-574	-112	-125	-64
Net Cash Flow Net Cash FlowCr	5	-3	-2	-5	1	0	0	0	0	0	0
Free Cash Flow Free Cash FlowCr	-127	-188	-38	-3	-52	134	166	576	112	125
CFO To PAT CFO To PAT%	-36.8	155.3	133.3	-2.5	-49.7	-114.1	-149.3	-322.5	-98.5	-103.0	0.6
CFO To EBITDA CFO To EBITDA%	141.1	1,194.8	79.3	11.6	-162.2	-692.0	-14,217.7	-2,701.4	-765.1	-1,064.5	3.2

Ratios

Consolidated

Standalone

Financial Year	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	257	228	89	55	121	81	48	26	7	9	15
Price To Earnings Price To Earnings	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.2
Price To Sales Price To Sales	0.8	0.7	0.3	0.2	0.5	0.3	0.2	0.8	0.2	0.8	1.8
Price To Book Price To Book	0.9	1.1	0.5	0.5	2.8	-0.3	-0.1	-0.1	0.0	0.0	0.0
EV To EBITDA EV To EBITDA	45.0	-49.3	-7.6	39.5	-19.7	-37.8	-537.7	-7.7	-7.8	-9.9	-8.1
Profitability Ratios Profitability Ratios
GPM GPM%	45.6	40.7	39.8	51.9	29.4	33.0	35.7	79.8	80.2	53.5	35.6
OPM OPM%	4.2	-4.3	-27.7	5.5	-13.7	-8.4	-0.5	-55.2	-46.1	-96.8	-176.6
NPM NPM%	-16.1	-32.9	-16.5	-25.8	-44.8	-51.3	-49.9	-462.0	-357.9	-1,000.3	-898.4
ROCE ROCE%	0.0	-5.3	2.0	-2.6	-6.4	-7.0	-5.8	22.9	6.5	4.8	0.4
ROE ROE%	-17.9	-49.5	-24.2	-60.6	-37.9	196.7	62.5	30.7	19.1	17.0	9.3
ROA ROA%	-6.3	-12.9	-5.5	-8.6	-10.9	-12.9	-12.6	-27.4	-20.7	-21.4	-15.8
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Simplify stock analysis with powerful tools and insights, empowering data-driven decisions effortlessly

Data provided by CMOTS Internet Technologies

Legal

Terms Privacy About Us Contact Us

Resources

Pricing Tutorials

Tools

Stock Scans Result Scans Market Scans Announcement Scans Shareholding Scans Custom Index

support@stockscans.in

349 A, Lodhi Road, Punjabi Bazar, New Delhi